The Childhood Eye Cancer Trust Research Grants 2026–2027 provide up to £25,000 for research improving the understanding, treatment and long-term impact of retinoblastoma. Applications are welcomed internationally, provided the project demonstrates potential benefit for the UK retinoblastoma community.
The program supports research into disease patterns, treatments with fewer side effects, preservation of vision and the consequences of retinoblastoma for patients and families. The current call also highlights psychosocial research, including the psychological effects of diagnosis, treatment and survivorship.
Eligibility and Project Requirements
- Researchers from any country may apply.
- Projects must focus on retinoblastoma.
- Research must demonstrate potential benefit for the retinoblastoma community in the United Kingdom.
- Proposals must align with CHECT’s research strategy.
- Applications must address at least one James Lind Alliance Priority Setting Partnership Priority for Children’s Cancer.
- Projects should improve understanding of the disease, advance kinder treatments or reduce its impact on affected people.
- Most funded research is expected to demonstrate benefit within five to ten years after the grant ends.
Funding Details
- Maximum award: £25,000.
- Supports research across the field of retinoblastoma.
- Psychosocial research addressing the experiences of patients and families is also welcomed.
- Applications undergo scientific review, with final funding decisions made by CHECT’s Board of Trustees.
Deadline
- Application deadline: December 4, 2026.
- Application status: Open.